Company Filing History:
Years Active: 1993-1996
Title: Barry C Peterson: Innovator in Pharmaceutical Chemistry
Introduction
Barry C Peterson is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of intermediates and processes that enhance the efficacy of central nervous system (CNS) agents.
Latest Patents
Among his latest patents, one includes the invention of intermediates to 4-amino-hexahydrobenz(cd)indoles and processes. This innovation provides an efficient method for deriving 4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles, which serve as intermediates to useful CNS agents. The preferred embodiments of this patent offer means for the preparation of substantially pure enantiomers of the desired compound. Another significant patent involves the stereocontrolled synthesis of cis-bicyclic compounds. This invention outlines a process for synthesizing various cis-bicyclic compounds, including cis-hexahydro-6-isoquinolones and cis-dihydroisochromanones.
Career Highlights
Barry C Peterson is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Barry has collaborated with esteemed colleagues, including Michael J Martinelli and Thomas J Kress. These collaborations have further enriched his research and innovation efforts.
Conclusion
Barry C Peterson stands out as a prominent inventor in the pharmaceutical field, with a focus on developing innovative processes and intermediates. His contributions continue to impact the development of CNS agents, showcasing the importance of his work in advancing medical science.